Development of Vitiligo in Patients Treated with BRAF/MEK Inhibitors: A Systematic Review
收藏Mendeley Data2024-01-31 更新2024-06-28 收录
下载链接：
https://data.mendeley.com/datasets/gvzfkkjyks
下载链接
链接失效反馈官方服务：
资源简介：
BRAF and MEK inhibitors have emerged as key therapies in the treatment of metastatic melanoma through selective inhibition of the mitogen activated protein kinase (MAPK) pathway. A rare side effect of BRAF and MEK inhibitors is the development of vitiligo. This systematic review aims to summarize the existing literature on new-onset or exacerbations of vitiligo following BRAF, MEK, or BRAF/MEK combination inhibitor therapy.
创建时间：
2024-01-31
